Literature DB >> 31803686

Acute pancreatitis as an initial presentation of Crohn's disease: A case report.

Norah Mohammed Almarri1, Alaa Jamal Alobaidli1, Ahmed Abdullah Almarhabi1, Mohammed Ahmed Alshammari1.   

Abstract

Acute pancreatitis (AP) is not commonly known to be an extra-intestinal manifestations of Crohn's disease (CD). Several cases have been reported discussing the relation of AP with CD. However, no specific etiological factors for pancreatitis were found, which appears to support the possibility of a relationship between AP and CD. We report a 30-year-old male present with generalized abdominal pain associated with watery diarrhea. Diagnosis of AP was made. A CT abdomen showed pancreatic inflammation with a terminal ileum thickening. Colonoscopy with multiple biopsy was done for the patient, which confirmed the diagnosis of CD. The patient started on adalimumab for 6 months, showed good response, and became symptomatically free. No recurrent attacks after 2 years of follow-up. The association between AP and CD is not yet clear. Therefore, patients presenting with idiopathic pancreatitis should be investigated to rule out the coexistence of IBD for better outcome. Copyright:
© 2019 Journal of Family Medicine and Primary Care.

Entities:  

Keywords:  Acute pancreatitis; Crohn's disease; autoimmune pancreatitis; extra-intestinal manifestation; inflammatory bowel disease

Year:  2019        PMID: 31803686      PMCID: PMC6881938          DOI: 10.4103/jfmpc.jfmpc_753_19

Source DB:  PubMed          Journal:  J Family Med Prim Care        ISSN: 2249-4863


  10 in total

Review 1.  Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease.

Authors:  Anet A Soubières; Andrew Poullis
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

2.  Editorial: relative efficacy of infliximab and adalimumab in Crohn's disease in an Australian and New Zealand cohort.

Authors:  M Barreiro-de Acosta; J P Gisbert
Journal:  Aliment Pharmacol Ther       Date:  2017-03       Impact factor: 8.171

3.  Crohn's disease and acute pancreatitis. A review of literature.

Authors:  Sarfaraz Jasdanwala; Mark Babyatsky
Journal:  JOP       Date:  2015-03-20

4.  Crohn's disease presenting with acute pancreatitis.

Authors:  K Moubax; F Mana; D Urbain
Journal:  Acta Gastroenterol Belg       Date:  2014-09       Impact factor: 1.316

5.  Idiopathic pancreatitis preceding the diagnosis of inflammatory bowel disease is more frequent in pediatric patients.

Authors:  Efrat Broide; Iris Dotan; Batia Weiss; Michael Wilschanski; Baruch Yerushalmi; Aharon Klar; Arie Levine
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-06       Impact factor: 2.839

Review 6.  Pancreatitis in inflammatory bowel diseases.

Authors:  C S Pitchumoni; Amy Rubin; Kiron Das
Journal:  J Clin Gastroenterol       Date:  2010-04       Impact factor: 3.062

7.  Type 2 Autoimmune Pancreatitis with Crohn's Disease.

Authors:  Yoon Suk Lee; Nam-Hoon Kim; Jun Hyuk Son; Jung Wook Kim; Won Ki Bae; Kyung-Ah Kim; June Sung Lee
Journal:  Intern Med       Date:  2018-03-09       Impact factor: 1.271

Review 8.  Pancreatic Involvement in Inflammatory Bowel Disease: A Review.

Authors:  Fotios S Fousekis; Vasileios I Theopistos; Konstantinos H Katsanos; Dimitrios K Christodoulou
Journal:  J Clin Med Res       Date:  2018-09-10

Review 9.  Crohn's disease of esophagus, stomach and duodenum.

Authors:  Andréa Maia Pimentel; Raquel Rocha; Genoile Oliveira Santana
Journal:  World J Gastrointest Pharmacol Ther       Date:  2019-03-07

Review 10.  A Review of Extraintestinal Manifestations and Complications of Inflammatory Bowel Disease.

Authors:  Vito Annese
Journal:  Saudi J Med Med Sci       Date:  2019-04-12
  10 in total
  1 in total

Review 1.  Systematic review-pancreatic involvement in inflammatory bowel disease.

Authors:  Sara Massironi; Ilaria Fanetti; Chiara Viganò; Lorena Pirola; Maria Fichera; Laura Cristoferi; Gabriele Capurso; Pietro Invernizzi; Silvio Danese
Journal:  Aliment Pharmacol Ther       Date:  2022-05-03       Impact factor: 9.524

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.